Microplastics Detected in 90% of Prostate Tumors in U.S. Pilot Study
A recent pilot study from NYU Langone Health has revealed a concerning presence of microplastics within human prostate cancer tissues. The findings, presented during an oncology symposium in late February 2026, suggest that these invisible plastic fragments are not only present in the body but are found in higher concentrations within malignant tumors than in healthy tissue.
The research focused on ten patients who underwent complete surgical removal of the prostate due to cancer. By comparing samples from tumor sites against neighboring benign tissues, researchers aimed to quantify the level of plastic exposure within the organ. This discovery highlights the growing concern over how permanent exposure to environmental pollutants may interact with human biology.
According to the study data, microplastics were detected in 90% of the tumor samples, compared to 70% of the benign tissue samples. More significantly, the concentration of these particles was approximately 2.5 times higher in the cancerous areas. On average, tumor tissues contained around 40 micrograms of plastic per gram of tissue, while non-cancerous tissues contained about 16 micrograms per gram.
To ensure accuracy and avoid generalized results, the research team analyzed 12 specific families of common polymers. The study utilized specialized instrumentation to characterize the composition and mass of the particles found in the surgical samples.
While the objective of this pilot study was to quantify exposure rather than provide a clinical diagnosis, the results raise critical questions regarding the role of inflammation and the potential biological impact of these pollutants. As microplastics continue to permeate the air, water, and food supply, their accumulation in critical organs may provide novel avenues for understanding cancer progression and public health risks.
